Article Text

other Versions

PDF
Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions
  1. Rick A Nishimura,
  2. Carole A Warnes
  1. Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
  1. Correspondence to Dr Rick A Nishimura, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA; nishimura.rick{at}mayo.edu

Abstract

The management of women with mechanical heart valves during pregnancy remains difficult and controversial. There is no ideal anticoagulation regimen for this unique population, as there are inherent risks and benefits of each approach for both mother and fetus. There has been limited data available to guide the clinician in the optimal treatment strategy for an individual patient. The AHA/ACC Guidelines for the Management of Patients with Valvular Heart Disease created class recommendations for this population based upon current evidence, which is summarized in this review.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles